Successful extracorporeal membrane oxygenation-assisted treatment for a kidney transplant recipient infected with severe COVID-19
- Author:
Dongdong Li
1
Author Information
- Publication Type:Case Reports
- Keywords: extracorporeal membrane oxygenation; COVID-19; kidney transplant
- From: World Journal of Emergency Medicine 2024;15(5):416-418
- CountryChina
- Language:English
- Abstract: Clinical practice has shown that kidney transplant recipients infected with COVID-19 are prone to developing critical illness and have a higher mortality rate.[1] Kidney transplant recipients require long-term oral anti-rejection drugs to suppress the immune response. This result may be related to the strong immunosuppression in kidney transplant recipients compared to the general population.[2] Therefore, the treatment of kidney transplant recipients infected with severe COVID-19 is a difficult problem. Here, we report the use of extracorporeal membrane oxygenation (ECMO)-assisted treatment for a kidney transplant recipient who was infected with severe COVID-19.
